A composition of matter includes a mixture of styrene derivative monomers and methacrylate/acrylate derivative monomers, which have one or more urethane, carbamate, amide, and/or amine functional groups, and initiators, and the compositions are used to achieve composition control of the forming polymer, with the mole fraction of acrylate/methacrylate and styrene moieties in the forming polymer determined preferably by the chemistry and composition of the feeding monomers rather than the viscosity of the monomers.

The invention relates to fine and uniform copolymer powders of partial mixed metal salts of lower alkyl vinyl ether-maleic acid copolymers having a defined particle size distribution. In particular; it relates to powders that are suitably used in the areas of oral care and pharmaceuticals and to methods for preparing the powders. Provided is a composition of powders of partial mixed metal salts of lower alkyl vinyl ether-maleic acid copolymers having: (i) a Dv50 of less than or equal to 25 microns; a Dv90 of less than or equal to 50 microns; and (ii) a particle uniformity reflected by a Dv90/Dv10 ratio of less than or equal to 10.

Disclosed is a water-based coating composition having as a base resin, a core/shell type emulsion resin comprising an acrylic resin as the core portion and a polyurethane resin as the shell portion, wherein the mass ratio of the core portion and the shell portion in the aforementioned core/shell type emulsion resin is between 20/80 and 80/20, the aforementioned acrylic resin has a hydroxyl group value of 40 to 140 mg KOH/g and an acid value of 0 to 10 mg KOH/g, the aforementioned polyurethane resin has a hydroxyl group value of 20 to 80 mg KOH/g and an acid value of 10 to 60 mg KOH/g, and the total mass ratio of constituent units derived from dibasic acids and/or dihydric alcohols having 10 to 60 carbon atoms in the aforementioned polyurethane resin is 10 to 50 mass % relative to the solid resin content of the aforementioned polyurethane resin.

Disclosed is a water-based coating composition having as a base resin, a core/shell type emulsion resin comprising an acrylic resin as the core portion and a polyurethane resin as the shell portion, wherein the mass ratio of the core portion and the shell portion in the aforementioned core/shell type emulsion resin is between 20/80 and 80/20, the aforementioned acrylic resin has a hydroxyl group value of 40 to 140 mg KOH/g and an acid value of 0 to 10 mg KOH/g, the aforementioned polyurethane resin has a hydroxyl group value of 20 to 80 mg KOH/g and an acid value of 10 to 60 mg KOH/g, and the total mass ratio of constituent units derived from dibasic acids and/or dihydric alcohols having 10 to 60 carbon atoms in the aforementioned polyurethane resin is 10 to 50 mass % relative to the solid resin content of the aforementioned polyurethane resin.

The present invention provides a dental adhesive exhibiting excellent initial bond strength and bond durability to both enamel and dentin. The present invention relates to a dental adhesive containing: an asymmetric acrylamide-methacrylic acid ester compound (a); an acid group-containing (meth)acrylic polymerizable monomer (b); and a water-soluble polymerizable monomer (c). The asymmetric acrylamide-methacrylic acid ester compound (a) is represented by the following general formula (1): ##STR00001##
where X is an optionally substituted, linear or branched C.sub.1 to C.sub.6 aliphatic group or an optionally substituted aromatic group, the aliphatic group is optionally interrupted by at least one linking group selected from the group consisting of O, S, CO, COO, OCO, NR.sup.1, CONR.sup.1, NR.sup.1CO, COONR.sup.1, OCONR.sup.1, and NR.sup.1CONR.sup.1, and R.sup.1 is a hydrogen atom or an optionally substituted, linear or branched C.sub.1 to C.sub.6 aliphatic group.

A cationically polymerizable curable composition comprising a compound having a vinyloxy group bonded to an aromatic group which is easily cured upon light exposure and/or heating, a cured product of the curable composition, and a method of producing a cured product using the curable composition. In a cationically polymerizable curable composition that includes a compound having a vinyloxy group bonded to an aromatic group, a sulfonium salt having a specific structure is used as a curing agent. A cured product is produced by shaping the curable composition into a predetermined shape, and subjecting the shaped curable composition to light exposure and/or heating.

A cationically polymerizable curable composition comprising a compound having a vinyloxy group bonded to an aromatic group which is easily cured upon light exposure and/or heating, a cured product of the curable composition, and a method of producing a cured product using the curable composition. In a cationically polymerizable curable composition that includes a compound having a vinyloxy group bonded to an aromatic group, a sulfonium salt having a specific structure is used as a curing agent. A cured product is produced by shaping the curable composition into a predetermined shape, and subjecting the shaped curable composition to light exposure and/or heating.

The present invention relates to: a polymer composition; an article; a medical device; an article production method; and a cell cluster production method. The polymer composition contains a polymer having the following repeating units (A) and (B) and is one selected from the group consisting of a medical device composition, a cell adhesion inhibitor, and a silicone substrate treatment composition: (A) a hydrophilic repeating unit; and (B) a repeating unit which has a polyoxyalkylene group in a side chain whose terminal is constituted by an alkyl group having 5 to 30 carbon atoms, an alkanoyl group having 5 to 30 carbon atoms, or an aryl group having 6 to 30 carbon atoms.

The present invention relates to: a polymer composition; an article; a medical device; an article production method; and a cell cluster production method. The polymer composition contains a polymer having the following repeating units (A) and (B) and is one selected from the group consisting of a medical device composition, a cell adhesion inhibitor, and a silicone substrate treatment composition: (A) a hydrophilic repeating unit; and (B) a repeating unit which has a polyoxyalkylene group in a side chain whose terminal is constituted by an alkyl group having 5 to 30 carbon atoms, an alkanoyl group having 5 to 30 carbon atoms, or an aryl group having 6 to 30 carbon atoms.

The present invention relates to: a sealing gel having a Mooney viscosity (ML1+4 @ 100 C.) in the range from 100 MU to 170 MU, a sealing compound comprising inventive sealing gel, a process for producing this sealing compound, the use of sealing gels for improving viscoelastic properties in sealing compounds, and the use of sealing gel-containing sealing compounds for improving rolling resistance properties in tyres having sealing layers.